Nanopacli 100mg Injection is a vital medication used in the treatment of various cancers. Its active ingredient, Paclitaxel, is a potent chemotherapy agent belonging to the taxane class. Paclitaxel works by interfering with the normal breakdown of microtubules, which are essential components of cell division. By disrupting this process, Nanopacli effectively inhibits the proliferation of rapidly dividing cancer cells, leading to tumor shrinkage and control.
This injection is primarily indicated for the treatment of metastatic breast cancer, ovarian cancer, and non-small cell lung cancer. It may also be used in other specific oncological conditions as determined by a healthcare professional.
The dosage and administration of Nanopacli 100mg Injection are strictly determined by the treating physician based on the type and stage of cancer, as well as the patient’s overall health. It is typically administered intravenously.
Common side effects associated with Nanopacli include bone marrow suppression (leading to decreased blood cell counts), peripheral neuropathy (numbness, tingling, or pain in the hands and feet), hair loss, nausea, vomiting, and allergic reactions. Patients should report any unusual or severe side effects to their doctor immediately.
Nanopacli 100mg Injection should be stored at room temperature, protected from light, and should not be frozen. It is crucial to follow all storage instructions provided by the manufacturer and healthcare provider.
